Home > SANTE - SCIENCES DE LA VIE > Industrie Pharmaceutique > Pharmaceutical industry ...
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS

Pharmaceutical industry market in USA

 
Anglais, PDF, Juin 2003, 20 pages
VISUALISER
TRANSFERER
AJOUTER AUX FAVORIS




 
 
   
Secteur analysés : pharmaceutical,pharmaceuticals,clinical trials,...,...
Type d'analyse : market size and estimates,market outlook,...
Marché traités : usa,united kingdom,japan
   
Essayez une nouvelle recherche :
 
 
Votre E-mail:
Votre Mot de Passe :
  €39
 




 
Email:
Choisissez un mot de passe:
Confirmez votre mot de passe:
 
pipeline,  venture capital,  analgesics,  arthritis,  biotech,  biotechnology,  breast cancer,  cancer,  cardiovascular disease,  cell therapy,  central nervous system,  clinical trial,  clinical trials,  cosmetic,  diabetic,  drug discovery,  drug discovery technology,  gene therapy,  genomics,  health care,  healthcare,  human genome,  immunotherapy,  ingredient,  ingredients,  kidney transplantation,  life sciences,  mobile handsets,  mobile phone,  mobile phones,  nanomagnetic,  nanomagnetics,  neuropathic pain,  parkinson,  pdas,  pharmaceutical,  pharmaceutical industry,  pharmaceuticals,  pharmacogenomics,  rheumatoid arthritis,  savings,  semi-conductor,  semiconductor,  semiconductors,  shortening,  software,  spread,  therapeutic drug,  vaccines,  venture capital,  
prelude trust plc corporate update investment trusts recen early stage technology portfolio performed better than principal benchmark final results for the y market decline n investments declined b impact affe which accounted 96 made significant prog part of in nexan and making pro three quoted companies remaining shareholding 2 7 times its cost a performe ftse techmark all sh demon strated excellent cash manage ment difficult climate or trade sale tr 11 compa partners to raise e were mad had further funding forec new financing rounds f months current year fin with most investees substantial progress despite downturn i was by areas fillfactory zbd display mobile communications infrastructure polatis ph life science fields sc sales while de novo successfull roche saleable products overall five unquoted are services alphamosaic several others more service recovery figs 000 31 st march return deficit before tax 2001 5 816 2002 3 861 2003 16 679 shares issue 36 7m fully
>> Pharmaceutical industry market in USA >>
 
DPLSEN
New Search:
© Plusdetudes 2007